ArticleFrontiers in pharmacology2022

Di'ao Xinxuekang Capsule Improves the Anti-Atherosclerotic Effect of Atorvastatin by Downregulating the SREBP2/PCSK9 Signalling Pathway.

Jiyi Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.